Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 02, 2021 08:30 ET | Source: NeurMedix, Inc.

NeurMedix Obtains FDA Authorization for Pivotal Phase 3 Alzheimer’s Trial

SAN DIEGO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- NeurMedix, LLC, a San Diego based privately held clinical stage pharmaceutical company announced that it has received authorization from the U.S. Food...